Health Technology

MobileSmith Health Announces Go-Live at CHI St. Vincent Infirmary

MobileSmith Health

MobileSmith a leading provider of cutting-edge mobile software solutions, announces delivery and live status of their PeriOp solution at CHI St. Vincent Infirmary.

MobileSmith Health is proud to partner with CHI St. Vincent in improving throughput and clinical care for surgical patients using the PeriOp solution. This toolset provides visibility of patient activities and status to the clinical team preparing to welcome patients for surgery. The adherence dashboard helps clinicians focus on the patients who need the most help. Patients, in turn, get education about their procedure, complete necessary preoperative tasks, and are better prepared to manage their care at home.

"We are thrilled to partner with CHI St. Vincent and their innovative team. Our work addresses patient outcomes while improving patient satisfaction. It also reduces the workload of clinical staff by automating routine tasks and improving predictability in patient throughput,"

Chris Caramanico, Chief Executive Officer of MobileSmith Health

"The MobileSmith Health team has been a pleasure to work with. We have a shared vision and passion to make healthcare communication to the patient reliable and more efficient. The combination of MobileSmith Health and our talented and innovative team at CHI St. Vincent are proving that we can make a difference in the daily work of many clinicians while improving patient outcomes," said Dr. Jill Flaxman, Medical Director of Perioperative Services.

About MobileSmith
MobileSmith Health is a digital health technology company focused on increasing efficiency and improving outcomes by providing clinicians with modern pre- and post-surgery dashboard, showing how patients participate in their own care. PeriOp, MobileSmith Health’s patient app, connects providers to their patients, streamlines information, simplifies surgery preparation and discharge and reduces complications. PeriOp by MobileSmith Health makes the science, process and oversight simple.

Spotlight

Spotlight

Related News

Health Technology, Digital Healthcare

HARMAN Launches New Private Large Language Model for Healthcare Industry- HARMAN HealthGPT

Business Wire | October 16, 2023

HARMAN, a wholly-owned subsidiary of Samsung Electronics Co., Ltd. focused on connected technologies for automotive, consumer, and enterprise markets, announced that its Digital Transformation Solutions business unit has launched the groundbreaking Healthcare Private Language Model (LLM), known as HealthGPT. HealthGPT represents a leap in healthcare solutions by leveraging generative AI to empower healthcare professionals, researchers, and institutions through advanced patient care, medical research, and decision-making. HealthGPT brings forward all the benefits of a LLM like natural language interaction and learnability, with a strong knowledge base established from a variety of healthcare data sets. The model, built using the key principles of responsible AI, has additionally been tested for accuracy and hallucinations using HARMAN’s own automated LLM testing framework and the results were further validated by the healthcare subject matter experts. HARMAN HealthGPT is a private LLM, providing enterprises with more control over roadmap, privacy, compliance and security issues at optimized cost. Key advantages of working with HARMAN HealthGPT include Enhanced Clinical Insights: Provides real-time, context-aware clinical insights, aiding in decision making. End-to-end LLM Fine tuning framework: A comprehensive framework for fine-tuning Language Model (LLM) to achieve optimal performance. Data generation framework: A framework for creating high quality customized datasets to further fine-tune Language Model (LLM) for enhanced performance. Automated LLM evaluation framework: Completely automated solution to validate fine-tuned LLMs for quality of outputs, factual correctness, hallucinations, and toxicity. Cost Optimization: Advanced deployment techniques using quantization to significantly reduce model size and thereby processing costs by up to one-tenth. Drug Discovery and Research: Accelerate drug discovery and development by extracting valuable insights from clinical trial data. Nick Parrotta, President – Digital Transformation Solutions & Chief Digital and Information officer at HARMAN said, The business value of generative AI cannot be overstated. Organizations that scale and implement swiftly will see significant competitive advantages, productivity gains and more – but only if they can unlock their data and move from general purpose applications to more specialized, domain-specific applications. At HARMAN, it is our mission to help our clients navigate this hurdle and create a competitive advantage long-term. HARMAN HealthGPT is an example of our capabilities that will help organizations utilize specific industry trained models to better solve unique problems and add value for customers. With our long-standing AI expertise and ability to develop effective LLMs, we’re equipped to help our clients move past challenging roadblocks and fully capitalize on the exciting promise of generative AI. [Source – Business Wire] HARMAN is seeing strong early results of the LLM training, and its AI and ML teams are well positioned with an end-to-end, tested framework to fine-tune more private LLMs, beyond the healthcare industry, to solve similar customer problems.

Read More

Healthcare Analytics

Maxim Healthcare Services Names National Caregiver of the Year

Business Wire | September 29, 2023

Barbara Buttchen has been named National Caregiver of the Year by Maxim Healthcare Services (Maxim), a national provider of home healthcare, personal and behavioral care. Buttchen, a nurse in Maxim’s Madison, Wisconsin office was presented with the John “Doc” Langley National Caregiver of the Year award alongside colleagues and fellow nominees during a ceremony in Baltimore, Maryland on September 19. “Barbara makes such a difference in the lives of her patients and their families every day,” said Maxim’s Chief Executive Officer, Jarrod DePriest. We deeply admire Barbara’s dedication to providing quality compassionate in-home care and we are thrilled to present her with this much-deserved recognition. [Source – Business Wire] Selected by a panel of judges for her impactful contributions to the home healthcare community, Buttchen has worked as a nurse for more than 50 years. Described by her colleagues as one of the most selfless, caring, kind, and hard-working individuals, Buttchen prioritizes others’ well-being more than her own. She currently lives with lymphoma but keeps a positive attitude and is always looking for ways to serve others. She extends caregiving to her personal life with activities such as delivering Meals on Wheels to individuals in need, providing care to a friend that has Alzheimer's, and also lending her expertise to a friend’s husband that is wheelchair bound while they travel, so that the vacation can be safe and enjoyable. During the ceremony Barbara shared, “I wanted to be like Florence Nightingale. That’s how I want to be known and live my life. Before I lay my head down on the pillow, I want to make rounds one more time, with the lantern, to see if there’s someone that needs my care. Thank you so much for this honor.” Maxim’s Caregiver of the Year Award Program, which is celebrated annually, recognizes the nurses, home healthcare aides and behavioral direct care workers who all play a vital role in providing compassionate, holistic care for patients who are both medically fragile and who require behavioral and community support. Learn more about Buttchen’s story, here. In addition to honoring Buttchen, Maxim also celebrates another significant milestone this year – providing 35 years of compassionate, holistic home healthcare for patients. DePriest, who has been with Maxim since 1998 and first started with the company as a healthcare recruiter, lauds the Maxim team for this accomplishment. “The healthcare industry has continued to rapidly grow and evolve, and likewise so has Maxim,” said DePriest. “As a mission-driven company, we are passionate about our work and improving the lives of our patients, their families and the communities we serve nationwide. I want to thank our exceptional team for their commitment and service, and to our patients and their families that have welcomed us into their homes.”

Read More

Health Technology

DuPont Collaborates with STMicroelectronics (ST) to Develop New Smart Wearable Device Concept for Monitoring Biosignals

PR Newswire | November 03, 2023

DuPont announced that DuPont™ Liveo™ Healthcare Solutions is collaborating with STMicroelectronics a global leader in semiconductor technology serving customers across the spectrum of electronics applications, to develop a new smart wearable device concept for remote biosignal-monitoring. "Dedicated Liveo™ research teams collaborate with suppliers and manufacturers worldwide to create solutions across a vast array of medical applications – including smart devices that can share data between patients and doctors," said DuPont™ Liveo™ Global Business Leader Eugenio Toccalino. "The wearable device concept that resulted from the collaboration between DuPont and ST is the DuPont™ Liveo™ Smart Biosensing Patch prototype, which employs multifunctional microsensors and control electronics from ST embedded in a flexible patch design from DuPont." By collaborating with others across the healthcare ecosystem – from technology developers and material suppliers to device fabricators and OEMs – DuPont is developing more patient-centric solutions that contribute to better patient outcomes. Simone Ferri, STMicroelectronics AMS Group Vice-President and MEMS sub-group General Manager. ST designed the electronics and sensors for the smart skin patch prototype using our accelerometer and vertical analog front end next-generation sensors with in-sensor AI, a microcontroller with Bluetooth module, ultra-low-power-management units, firmware, and algorithm support to create a flexible board design capable to analyze electrical and mechanical heart activity in full synchronization to extract multiple vital signs. The performance of ST's electronic sensors is enhanced by the conformability and conductivity of the DuPont™ Liveo™ materials used to create the patch. [Source: PR Newswire] Through this collaboration, DuPont brings a broad range of medical patch technologies, including DuPont™ Liveo™ Soft Skin Conductive Tape 1-3150 – a silicone-based thermoset adhesive for sensing and transferring electrical biosignals, and Liveo™ Soft Skin Adhesives. ST's sensor and embedded development technology and semiconductor manufacturing expertise, combined with the key benefits of silicone technology with electrically conductive properties allow Liveo™ Soft Skin Conductive Tape technology to be used as a skin electrode for biosignal-monitoring applications where good skin conformability, no drying over time, and repositionability with gentle adhesion and atraumatic removal is vital. It can be used in single electrodes for short-term monitoring, as well as in medical wearable patches for long-term monitoring lasting seven or more days. DuPont also designed the layout for the Liveo™ Smart Biosensing Patch and supplied rapid prototyping capabilities. The result of this collaboration is not just a single prototype, but a robust ST-empowered Liveo™ Smart Biosensing Patch technology toolbox for remote ECG and SCG monitoring. The DuPont and ST integrated patch technology is designed to improve people's lives, making it easier to use than typical rigid box designs. It's smaller, lighter, and more comfortable and can be worn longer. Plus, the sensors are multifunctional, intelligent, and adaptable, and the data provided is extremely stable. DuPont will demonstrate the capabilities of the Liveo™ Smart Biosensing Patch prototype at the MEDICA Trade Fair in Dusseldorf, Germany, November 13-16. The Liveo™ team will be in Hall 12/D33 in the Wearable Technologies Pavilion. As part of the MEDICA Connected Healthcare Forum, DuPont™ Liveo™ Healthcare Solutions Global Strategic Marketing Manager Jennifer Gemo and ST's Head of EMEA Healthcare and Well-Being Vertical Strategic Business Development Oriana Di Marco will present "Towards intelligent e-skin patches for cardiac monitoring" featuring the DuPont/ST collaborative patch concept and technology toolbox. The presentation will take place on Nov. 14 from 12:15 to 12:35 p.m. CEST in Hall 12/E37. DuPont offers a broad portfolio of high-performance, medical-grade elastomers, adhesives, resins and thermoplastics designed to meet the rigorous requirements of wearable medical devices. The company also provides support in the areas of materials research, application development, technology, safety and regulatory compliance. Whether for drug delivery or smart monitoring devices, DuPont™ Liveo™ Healthcare Solutions helps enable positive patient outcomes through increasingly advanced medical technology.

Read More